tiprankstipranks
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market
BLTE
Belite Bio, Inc. ADR
RESEARCH TOOLSreports
Want to see BLTE full AI Analyst Report?

Belite Bio, Inc. ADR (BLTE) Stock News & Sentiment

61 Followers
Buy Initiation on Tinlarebant Developer: First-Mover Stargardt Opportunity Drives DCF-Based $200 Target Amid Key Late-Stage Catalysts and Risks
Premium
Ratings
Buy Initiation on Tinlarebant Developer: First-Mover Stargardt Opportunity Drives DCF-Based $200 Target Amid Key Late-Stage Catalysts and Risks
7d ago
BLTE
Belite Bio Starts FDA Rolling NDA for Tinlarebant in Stargardt Disease
Premium
Company Announcements
Belite Bio Starts FDA Rolling NDA for Tinlarebant in Stargardt Disease
8d ago
6K
BLTE
Belite Bio Faces Higher Compliance Burden as It Becomes a Large Accelerated Filer, Raising Costs and Operational Risk
Premium
Company Announcements
Belite Bio Faces Higher Compliance Burden as It Becomes a Large Accelerated Filer, Raising Costs and Operational Risk
28d ago
BLTE
Belite Bio Posts 2025 Form 20-F Annual Report Online as Late-Stage Retinal Drug Trials Advance
Premium
Company Announcements
Belite Bio Posts 2025 Form 20-F Annual Report Online as Late-Stage Retinal Drug Trials Advance
29d ago
6K
BLTE
Belite Bio Eyes 2027 Launch After Pivotal Win
Premium
Company Announcements
Belite Bio Eyes 2027 Launch After Pivotal Win
2M ago
BLTE
Tinlarebant De‑Risking Milestones and Rare-Disease Upside Support Buy Rating and $200 Price Target
Premium
Ratings
Tinlarebant De‑Risking Milestones and Rare-Disease Upside Support Buy Rating and $200 Price Target
2M ago
BLTE
Belite Bio Posts 2025 Results as Tinlarebant Nears NDA Filing After Phase 3 Win
Premium
Company Announcements
Belite Bio Posts 2025 Results as Tinlarebant Nears NDA Filing After Phase 3 Win
2M ago
6K
BLTE
More BLTE News >

BLTE News on the Web

Why Belite Bio Stock Is Sliding Today
TipRanks News
Bearish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Belite Bio Jumps on Drug Hopes and Analyst Boost
TipRanks News
Bullish
Belite Bio Faces Higher Compliance Burden as It Becomes a Large Accelerated Filer, Raising Costs and Operational Risk
TipRanks News
Bearish
Belite Bio, Inc. ADR Shares Surge on Drug Progress
TipRanks News
Bullish
Belite Bio Posts 2025 Form 20-F Annual Report Online as Late-Stage Retinal Drug Trials Advance
TipRanks News
Neutral
Belite Bio Stock Stumbles as Traders Flee Rally
TipRanks News
Bearish
Belite Bio Eyes 2027 Launch After Pivotal Win
TipRanks News
Bullish

News Score - Last 7 Days

Negative
BLTE
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week0%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BLTE’s Media Buzz Sentiment?
1 articles about BLTE were published this week. In an average week, 1.5 articles are published.
    What is BLTE’s weekly average amount of articles?
    In an average week, 1.5 articles about BLTE are published.
      What is BLTE’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      TVTXTravere Therapeutics
      HVOOpen Orphan Plc
      PBMPsyence Biomedical
      QDELQuidelOrtho
      Showing the stocks with the most bullish news sentiment over the past week